International Dermatology COVID-19 Registry
A collaboration between ILDS and AAD: Dermatologic Manifestations of COVID-19, and existing dermatologic conditions in the setting of COVID-19
29 January 2021
The ILDS/AAD International COVID-19 Dermatology Registry is now capturing skin reactions to the COVID-19 vaccine. Healthcare providers from around the world are encouraged to enter cases.
The ILDS is working together with the American Academy of Dermatology (AAD) to support this international COVID-19 registry, directed by Prof. Esther Freeman from the Harvard Medical School in Boston, USA.
Any healthcare professional can contribute to the registry by filling out a brief form about a patient with a suspected or confirmed case of COVID-19 and noticeable skin changes. (https://redcap.partners.org/redcap/surveys/index.php?s=YJWAJCX7TY)
Healthcare professionals from around the world can now also enter cases, in the Dermatology Covid-19 Registry, for skin reactions to the COVID-19 vaccine.
Starting in December 2020, the International COVID-19 Dermatology Registry started capturing COVID-19 vaccine-related skin side effects. We encourage healthcare professionals from any country to submit cases to the registry of skin reactions they have seen with any of the COVID-19 vaccines. These may include local vaccine reactions in the arm, more generalised rashes, reactions at site of prior filler injections, or other.
The registry is de-identified, and we do not collect identifiable details about the patient. Our goal is to analyse the data in real time, to better inform vaccination programmes, and the public, about skin reactions in those receiving the COVID-19 vaccine.